Cue Biopharma Inc. (CUE)
NASDAQ: CUEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
CUE stock chart
Technical analysisKey statistics
All statistics- Market cap
- $163.52M
- EPS (TTM)
- -$29.59
- Dividend yield
- None
- 52-week range
- 4.98 – 45.50
- Day range
- 22.27 – 23.09
- Volume / Avg
- 132.22K / 268.50K
- Beta
- —
- Shares outstanding
- 7.26M
52-week range
CUE stock today
Cue Biopharma (CUE) closed at $22.51 on Oct 7, down 2.72% (-$0.63), versus the S&P 500's 0.22% decline. Trading was light, with 132.22K shares changing hands, about 49% of the average daily volume. Shares are 50.5% below their 52-week high of $45.50, set on Jul 10, 2026 and 352.0% above the 52-week low of $4.98, in the middle of the past year's range.
CUE is up 146.0% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 0.2%. Cue Biopharma has posted a net loss over the last twelve months (EPS of -$29.59), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Cue Biopharma
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2018
Cue Biopharma peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| DERMJourney Medical Corporation | 5.95 | -3.41% | $167.94M | vs CUE |
| VRXAVeraxa Biotech AG | 1.20 | +11.11% | $169.69M | vs CUE |
| ORGOOrganogenesis Holdings Inc. Class A | 1.32 | -1.49% | $169.85M | vs CUE |
| PEPGPepGen Inc. | 2.40 | +3.90% | $166.01M | vs CUE |
| NKTXNkarta Inc. | 2.27 | -1.73% | $162.59M | vs CUE |
| EMISEmmis Acquisition Corp. Class A | 10.27 | 0.00% | $162.02M | vs CUE |
| MSLESatellos Bioscience Inc. | 7.63 | +1.19% | $161.88M | vs CUE |
| YARWYarrow Bioscience Inc. | 18.78 | +0.24% | $174.69M | vs CUE |
Indexes, lists and sector
Cue Biopharma stock FAQ
What is Cue Biopharma's stock price today?
CUE last traded at $22.51 as of Oct 7, 4:00 PM EDT, down 2.72% on the day. Prices are delayed at least 15 minutes.
Does Cue Biopharma pay a dividend?
No. Cue Biopharma does not currently pay a regular cash dividend.
Has CUE ever split its stock?
Yes. The most recent CUE stock split was a 1-for-30 split on Apr 24, 2026.
What is the CUE 52-week high?
The 52-week high for CUE is $45.50 and the 52-week low is $4.98. The stock is currently 50.5% below its high.